OMIKRON S-Core · Q-Leap Research Program · 2026

The Physics
of Disease.

One framework. Every scale. Both directions.

OMIKRON S-Core is the first causal database that maps biological disease through the lens of physics — not molecular pathways, but physical operators, thermodynamic laws, and fractal invariance across scales. 19,969 curated records. Two disease domains. Seven universal laws.

Explore the Framework For Investors →
19,969 Causal records
2 Disease domains
7 Physical laws
14 Fractal patterns
91.4 Avg. evidence score

What is OMIKRON

Disease is not a
molecular accident.

"Cancer is not an alien. It is the necessary result of seven known physical laws applied to a biological system that has exceeded its operational limits."

— OMIKRON Framework Laws FL000001–FL000007

OMIKRON S-Core

S-Core is the computational engine — a database of 19,969 physically typed causal relationships, each describing not merely what causes what, but through which physical operator, at which scale, with which thermodynamic signature.

Every record carries three levels of evidence (L0 public, L1 medical, L2 specialist), a verified DOI, a Score and a Consensus index. The average evidence score across the database is 91.4 out of 100.

S-Core is not a literature summary. It is a structured argument — a physical model of disease expressed as a graph, queryable as a database, and falsifiable as a scientific theory.

The OMIKRON Framework (OF)

OF is the theoretical architecture that gives S-Core its meaning. Six physical laws — forced oscillator dynamics, thermodynamics, mechanobiology, biochemistry as parameter modulation, fluid dynamics, and phase transitions — plus a seventh that unifies them all: fractal invariance across scales.

Every record in the database maps to at least one of these laws. Every fractal record (FR) documents where the same physical pattern replicates identically at molecular, cellular, and systemic scale. Every framework law (FL) is a falsifiable prediction about biological systems — not a metaphor.

The framework predicts drug transferability across tumor contexts: IC50B = IC50A × (λB/λA). The tissue-agnostic approval of pembrolizumab for MSI-H tumors is the clinical proof of this principle.

Seven Laws

The physics
that governs disease.

Every tumor, every neurodegeneration, every systemic collapse — all describable through these seven equations already in the physics textbook.

FL000001 · FDO
Forced Damped Oscillator
m·ẍ + c·ẋ + kx = F(t) | κ = λc / √(Kecm·Kq)
The biological system loses its damping coefficient c. The tumor is the divergent state of an oscillator that has lost its shock absorbers. κ quantifies physical drug resistance independently of molecular targets.
FL000002 · THERMODYNAMICS
Second Law & Systemic Entropy
dS_ER/dt = P_trans + M_misfold − C_UPR − J_autophagy
Desmoplasia is not disorder — it is an alternative energy minimum. Triple Notch Therapy forces the cancer cell toward a proteotoxic singularity by zeroing all damping terms simultaneously.
FL000003 · MECHANOBIOLOGY
Stiffness as Signal
LSI = L_stroma × K_ecm / f_collagenI | D_frac ∈ [1, 2]
ECM stiffness above 8 kPa physically excludes immune cells and antibodies. D_frac > 1.75 predicts 10-year survival with HR=2.6 — better than histological grade.
FL000004 · BIOCHEMISTRY
Biochemistry as Physical Parameters
ERO1A↑ → K_ecm↑ | KRAS → F(t)↑ | GPX4 = c_ferroptosis
Every enzyme is a modification of a physical parameter at molecular scale. The same FDO equation governs all scales — the renormalization group makes drug transferability mathematically necessary.
FL000005 · FLUID DYNAMICS
Interstitial Pressure & Ionic Uptake
Jv = Lp·(ΔP − σ·Δπ) | Na⁺/K⁺ ratio → K_q
IFP 20–100 mmHg in tumors vs 0–3 mmHg in normal tissue physically excludes antibodies. The same potassium ion modulates G-quadruplex conformation and nephron synchronization — a fractal connection across scales.
FL000006 · PHASE TRANSITIONS
Unjamming & Epithelial Phase
p₀ = perimeter / √area | p₀ < 3.81 jammed; > 3.81 fluid
Metastatic invasion is a first-order phase transition. The AVB axis collapse triggers p₀ > 3.81 — the tissue melts. Measurable from a standard H&E slide. Preventable with t-VNS.
FL000007 · FRACTAL RG — THE UNIFIER
Scale Invariance & Renormalization Group
OP[A / low_scale] ~ OP[B / high_scale] | k_n / k_{n+1} ≈ constant → IC50_B = IC50_A × (λB/λA)
If the same physical operator governs a process at molecular and systemic scale with a constant ratio between parameters, the system is fractal. This is why pembrolizumab works tissue-agnostically in MSI-H — it targets a K-SYNC fractal, not a tissue-specific target. 14 fractal patterns identified in the database. Each predicts cross-context drug transferability.

The Omikron Framework

ON | OR — Oncology
or Rare Disease.

Three dataset types — all sharing the same physical grammar. Each can be activated or deactivated independently. Query across both to find the bifurcation point.

ON
Oncology
17,380
OF000001 – OF017401
Cancer pathways, synthetic lethality, immunotherapy, desmoplasia, metabolic reprogramming. 902 distinct tumor types. Score avg 91.9.
OR
Orphan & Rare
2,568
OF017402 – OF019969
Neurodegeneration, rare genetic diseases, proteopathies, systemic sclerosis. Alzheimer, Parkinson, ALS, Huntington, Fanconi and 946 more disease types.
XD
Cross Domain
21
FR + FL records
Fractal patterns and framework laws — universal by physical definition. Each XD record applies to both ON and OR simultaneously, with a measurable scaling ratio λ.
HS
Healthy System
—
Coming next
The physiological baseline — what the healthy oscillator looks like before the damping collapses. The reference state against which both ON and OR are measured.

40 Dataset Contexts — the semantic vocabulary

AXCPKX TXCXDX NXVXQX MXHXFX SXLXWX BXGXBB TKSWSH IBEB DX·ORVX·OR BB·ORFP·OR CX·ORMX·OR HX·ORWX·OR NX·ORTX·OR PPOX FRFLXD

■ ON · Oncology    ■ OR · Rare & Orphan    ■ XD · Cross Domain

Physical Operators

21 operators.
One grammar.

Every record uses exactly one OP_Code — a physical operator that specifies the type of causal relationship. 8 new operators introduced by the OR dataset describe processes absent in oncology: progressive resource exhaustion, kinetic trapping, virtual domain coupling.

K-SYNC
Kinetic synchronization across scales
5,346 records
K-STALL
Kinetic arrest — activation barrier increase
4,441 records
K-START
Kinetic forcing — proliferative signal
4,298 records
K-SHIFT
Kinetic regime shift
670 records
K-PUSH
Gradient-driven kinetic forcing
1,067 records
K-FLOW
Inhibitory flux propagation
1,020 records
K-BREAK
Threshold crossing — discontinuous transition
269 records
C-DAMP
Damping collapse — shock absorber failure
113 records
T-DRAIN
Resource exhaustion over time
506 records · OR
T-START
Exhaustion process initiation
218 records · OR
V-LINK
Virtual domain coupling
259 records · OR
K-TRAP
Kinetic trap — irreversible state
58 records · OR
RESOURCE_EXHAUSTION
System-level resource depletion
122 records · OR
Q-START
Quantum-step process initiation
33 records · OR
MAP
Structural mapping of relationship
361 records
CHECK
Validation checkpoint
544 records

■ New operators introduced by OR dataset · not present in oncology

The Central Question

Why does the same
collapse choose proliferation
or degeneration?

The database now contains both directions. The bifurcation emerges from the topology — not from molecular biology, but from which physical domain collapses first.

→ Oncology (ON)

The system maintains genomic self-reference. BIO_GENETIC → BIO_GENETIC has 709 arcs — the cancer amplifies through its own molecular domain. High stiffness ECM (k ↑) creates a selective environment for proliferating cells.

k high → ECM stiffness → proliferation
BIO_GENETIC domain dominant (1,420 arcs ON)
KINETICS → KINETICS loops (self-amplifying)
Desmoplasia = ordered bunker, not entropy
SAME
FORCING
F(t) ⟷ k decides
→ Degeneration (OR)

The system collapses through network feedback. CYBERNETICS and STAT_MECH dominate — the disease propagates through statistical accumulation in soft tissue (k ↓). Cells die progressively instead of proliferating.

k low → soft tissue → no proliferative selection
CYBERNETICS dominant (725 arcs OR)
STAT_MECH ratio OR/ON = 0.42 (highest)
T-DRAIN — progressive resource exhaustion

"The disease does not choose proliferation or degeneration. The tissue chooses — through its physical stiffness k. Hard tissue amplifies. Soft tissue exhausts. The same forcing, two destinations."

— OMIKRON Framework · Bifurcation Hypothesis · 2026

Domain Topology

CYBERNETICS is
the bridge that cannot fall.

Graph analysis of 19,969 records reveals a single critical bridge node, two structural gaps, and three XD records needed to complete the cross-disease topology.

Bridge Node · Critical
CYBERNETICS
Removing CYBERNETICS disconnects the domain graph into three separate components. 6,834 arcs — the largest single domain. It corresponds to the autonomic nervous system and systemic feedback — the AVB axis, vagal tone, HPA axis. Collapse here disconnects molecular physics from systemic physics. This is why AVB collapse is the topological precondition for both cancer and neurodegeneration.
Structural Gap · Critical
BIO_GENETIC
absent in OR
709 BIO_GENETIC → BIO_GENETIC arcs in ON. Zero in OR. Neurodegeneration does not self-amplify at the genomic level — it collapses at the system level. This is the physical signature of the bifurcation. Cross-disease XD records bridging this gap are the next phase of development — they will map the exact conditions under which genomic self-reference activates (cancer) versus network exhaustion dominates (degeneration).
New Frontier · XD Records
VIRTUAL_DOMAIN
and CSF dynamics
14 OR-only arcs through VIRTUAL_DOMAIN → FLUID_DYNAMICS describe the propagation of neural signals through cerebrospinal fluid — a physical process with no oncological equivalent. These are the seed of a future HS (Healthy System) dataset: the physics of the brain in homeostasis, against which neurodegeneration can be measured as a deviation from a precisely defined physical baseline.

For Investors & Partners

A new coordinate
system for disease.

⚗
FR Scaling Therapeutics
The first mathematically rigorous method to predict drug transferability across tumor contexts using fractal scaling ratios. IC50B = IC50A × (λB/λA). Reduces preclinical failures by predicting which drugs will work in context B before the experiment is run.
🔬
OMIKRON Diagnostic Triad
Three measurable parameters — HRV, zonulin, NLR/LBP — that capture the physical state of the biological oscillator. Predictive of immunotherapy response, disease progression, and metastatic timing. Measurable with existing clinical instruments.
⚡
κ (kappa) — Physical Drug Resistance
A companion diagnostic for any immunotherapy in desmoplastic tumors. κ > 1.0 predicts pembrolizumab resistance in PDAC with HR ≥ 1.5 — measurable from a fresh biopsy in 4 weeks. Addresses the $4B annual cost of checkpoint inhibitor non-response.
🧬
Cross-Disease Intelligence
The only database that maps both oncology (ON) and rare/orphan diseases (OR) through the same physical grammar. Cross-domain queries reveal bifurcation nodes — molecular targets that, when modulated, shift a system between proliferative and degenerative trajectories.

Development Roadmap

Phase 0
Now
IP Protection & Retrospective Validation
UIBM copyright deposit. Retrospective study (n=200–300 IRCCS patients): OMIKRON Triad as predictor of immunotherapy response. Budget < €15,000. Target: IRCCS Regina Elena, INT Milano, IEO.
Phase 1
6–18 mo
Interventional Pilot RCT
n=60 · t-VNS + Akkermansia vs placebo · 8 weeks pre-immunotherapy. Primary outcome: OMIKRON Triad normalization. Secondary: ORR at 6 months. Budget €80–120k.
Phase 2
18–36 mo
κ Validation & XD Bridge Records
Prospective κ measurement in PDAC biopsies. Cross-disease XD record construction (bifurcation nodes). HS (Healthy System) dataset launch. First SaMD regulatory submission.
Phase 3
36+ mo
SaMD — Software as Medical Device
CE Class IIa SaMD: OMIKRON diagnostic algorithm for immunotherapy candidate selection. Partnership target: SYNLAB, bioMérieux, Roche Diagnostics. Licensing of FR Scaling Therapeutics to pharma.

Contact

Ready to explore
the physics of disease?

OMIKRON S-Core is available for research partnerships, licensing discussions, and clinical collaboration. The framework is open to validation — and every prediction is falsifiable.

Get in Touch
DISCLAIMER: The OMIKRON Framework and S-Core database are research tools in development. All clinical predictions are hypotheses requiring prospective validation. Not approved for diagnostic or therapeutic use. Not for distribution prior to IP deposit. Evidence scores reflect literature-based curation; they do not constitute clinical validation.